Assessment of pulmonary hypertension in the pediatric catheterization laboratory: Current insights from the magic registry

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 6, 2010, Pages 865-873

  Hill, Kevin D ^a   Lim, D Scott ^b   Everett, Allen D ^c   Ivy, D Dunbar ^d   Moore, J Donald ^e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

Author keywords

cardiac catheterization; hemodynamics; pediatric; pulmonary hypertension; vasoreactivity

Indexed keywords

NITRIC OXIDE; VASODILATOR AGENT;

ADOLESCENT; ARTERIAL PRESSURE; ARTICLE; CHILD; CLINICAL PROTOCOL; CONGENITAL HEART DISEASE; DEMOGRAPHY; DISEASE ASSOCIATION; GENERAL ANESTHESIA; HEART CATHETERIZATION; HEMODYNAMICS; HUMAN; IDIOPATHIC DISEASE; INFANT; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; OXYGEN BREATHING; PEDIATRIC CARDIOLOGY; PULMONARY HYPERTENSION; REGISTER; SEDATION;

ADOLESCENT; ANALYSIS OF VARIANCE; ANESTHESIA, GENERAL; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; INFANT; LINEAR MODELS; LOGISTIC MODELS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY ARTERY; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES; VASODILATOR AGENTS;

EID: 78649674631     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22693     Document Type: Article

References (35)

1. Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54 (1 Suppl): S55-S66.
2. Chin KM, Rubin LJ,. Pulmonary arterial hypertension. J Am Coll Cardiol 2008; 51: 1527-1538.
3. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009; 119: 2250-2294.
4. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987; 107: 216-223. (Pubitemid 17137857)
5. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115: 343-349.
6. Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: Results from a national registry. Am J Respir Crit Care Med 2006; 173: 1023-1030.
7. Jing ZC, Xu XQ, Han ZY, et al. Registry and survival study in chinese patients with idiopathic and familial pulmonary arterial hypertension. Chest 2007; 132: 373-379.
8. Walker AM, Langleben D, Korelitz JJ, et al. Temporal trends and drug exposures in pulmonary hypertension: An American experience. Am Heart J 2006; 152: 521-526.
9. Stricker H, Domenighetti G, Popov W, Speich R, Nicod L, Aubert JD, Soler M,. Severe pulmonary hypertension: Data from the Swiss Registry. Swiss Med Wkly 2001; 131: 346-350.
10. McLaughlin VV, Presberg KW, Doyle RL, Abman SH, McCrory DC, Fortin T, Ahearn G,. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126 (1 Suppl): 78S-92S. (Pubitemid 38932344)
11. Goodman G, Perkin RM, Anas NG, Sperling DR, Hicks DA, Rowen M,. Pulmonary hypertension in infants with bronchopulmonary dysplasia. J Pediatr 1988; 112: 67-72.
12. Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, Mullen MP,. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: Clinical features and outcomes in the surfactant era. Pediatrics 2007; 120: 1260-1269.
13. de Buys Roessingh AS, Dinh-Xuan AT,. Congenital diaphragmatic hernia: Current status and review of the literature. Eur J Pediatr 2009; 168: 393-406.
14. Levin DL, Heymann MA, Kitterman JA, Gregory GA, Phibbs RH, Rudolph AM,. Persistent pulmonary hypertension of the newborn infant. J Pediatr 1976; 89: 626-630.
15. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54 (1 Suppl): S43-S54.
16. Rosenzweig EB, Feinstein J, Humpl T, Ivy DD,. Pulmonary arterial hypertension in children: Diagnostic work-up and challenges. Prog Pediatr Cardiol 2009; 27: 7-11.
17. Everett AD, Ringel R, Rhodes JF, et al. Development of the MAGIC congenital heart disease catheterization database for interventional outcome studies. J Interv Cardiol 2006; 19: 173-177.
18. Kinsella JP, Greenough A, Abman SH,. Bronchopulmonary dysplasia. Lancet 2006; 367: 1421-1431.
19. Drossner DM, Kim DW, Maher KO, Mahle WT,. Pulmonary vein stenosis: Prematurity and associated conditions. Pediatrics 2008; 122: e656-e661.
20. Douwes JM, van Loon RLE, Hoendermis ES, Talsma M, Roofthooft MTR, Hillege HL, RMF B,. Prevalence and prognostic value of acute pulmonary vasodilator response in children and adults with pulmonary arterial hypertension (Abs.). Eur Soc Cardiol 2009.
21. Balzer DT, Kort HW, Day RW, et al. Inhaled Nitric Oxide as a Preoperative Test (INOP Test I): The INOP Test Study Group. Circulation 2002; 106 (12 Suppl 1): I76-I81.
22. Barst RJ, Maislin G, Fishman AP,. Vasodilator therapy for primary pulmonary hypertension in children. Circulation 1999; 99: 1197-1208.
23. McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, Fortin TA, Loyd JE,. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126 (1 Suppl): 14S-34S. (Pubitemid 38932340)
24. Rich S, Kaufmann E, Levy PS,. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327: 76-81.
25. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, Gaine S,. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43 (12 Suppl S): 40S-47S. (Pubitemid 38759716)
26. Costa EL, Jardim C, Bogossian HB, Amato MB, Carvalho CR, Souza R,. Acute vasodilator test in pulmonary arterial hypertension: Evaluation of two response criteria. Vasc Pharmacol 2005; 43: 143-147.
27. Galie N, Ussia G, Passarelli P, Parlangeli R, Branzi A, Magnani B,. Role of pharmacologic tests in the treatment of primary pulmonary hypertension. Am J Cardiol 1995; 75: 55A-62A.
28. Ghofrani HA, Wilkins MW, Rich S,. Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension. Circulation 2008; 118: 1195-1201.
29. Sitbon O, Humbert M, Jais X, Ioos V, Hamid AM, Provencher S, Garcia G, Parent F, Herve P, Simonneau G,. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005; 111: 3105-3111.
30. Bush A, Busst CM, Haworth SG, Hislop AA, Knight WB, Corrin B, Shinebourne EA,. Correlations of lung morphology, pulmonary vascular resistance, and outcome in children with congenital heart disease. Br Heart J 1988; 59: 480-485.
31. Hoffman JI, Rudolph AM, Heymann MA,. Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. Circulation 1981; 64: 873-877.
32. Neutze JM, Ishikawa T, Clarkson PM, Calder AL, Barratt-Boyes BG, Kerr AR,. Assessment and follow-up of patients with ventricular septal defect and elevated pulmonary vascular resistance. Am J Cardiol 1989; 63: 327-331.
33. Kulik TMM, Adatia I,. Pulmonary arterial hypertension associated with congenital heart disease Prog Pediatr Cardiol 2009; 27: 25-33.
34. Carmosino MJ, Friesen RH, Doran A, Ivy DD,. Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization. Anesth Analg 2007; 104: 521-527.
35. Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol 2006; 48: 2546-2552.